PharmX Technologies Limited (ASX:PHX)
Australia
· Delayed Price · Currency is AUD 0.0780
0.00 (0.00%)
At close: May 13, 2025, 4:00 PM AEST
PharmX Technologies Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
Operating Revenue | 8.63 | 8.09 | 6.13 | 5.39 | 11.88 | 10.64 | Upgrade
|
| Revenue | 8.63 | 8.09 | 6.13 | 5.39 | 11.88 | 10.64 | Upgrade
|
Revenue Growth (YoY) | 37.45% | 32.10% | 13.78% | -54.65% | 11.58% | -5.23% | Upgrade
|
Cost of Revenue | 4.67 | 4.13 | 4.12 | 3.25 | 8.5 | 8.97 | Upgrade
|
Gross Profit | 3.97 | 3.96 | 2.01 | 2.14 | 3.38 | 1.67 | Upgrade
|
Selling, General & Admin | 2.68 | 2.64 | 1.7 | 1.15 | 0.98 | 0.77 | Upgrade
|
Research & Development | -0.19 | -0.14 | -0.09 | -0.1 | -0.62 | -0.59 | Upgrade
|
Other Operating Expenses | - | - | - | 0.09 | 0.02 | 0.16 | Upgrade
|
Operating Expenses | 3.76 | 3.72 | 2.67 | 2.01 | 2.16 | 1.16 | Upgrade
|
Operating Income | 0.21 | 0.24 | -0.67 | 0.13 | 1.22 | 0.52 | Upgrade
|
Interest Expense | -0.04 | -0.04 | -0.05 | -0.01 | -0.13 | -0.05 | Upgrade
|
EBT Excluding Unusual Items | 0.17 | 0.2 | -0.72 | 0.12 | 1.09 | 0.47 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | - | 1.73 | 1.78 | Upgrade
|
Asset Writedown | - | - | - | - | - | -1.47 | Upgrade
|
Other Unusual Items | - | - | - | - | -1.47 | -0.32 | Upgrade
|
Pretax Income | 0.17 | 0.2 | -0.72 | 0.12 | 1.35 | 0.46 | Upgrade
|
Income Tax Expense | 0.16 | 0.11 | 0.16 | 0.25 | 0.27 | 0.28 | Upgrade
|
Earnings From Continuing Operations | 0.01 | 0.1 | -0.88 | -0.13 | 1.08 | 0.18 | Upgrade
|
Earnings From Discontinued Operations | 0.1 | -1.86 | -0.17 | 0.38 | 0.01 | - | Upgrade
|
Net Income | 0.12 | -1.77 | -1.05 | 0.25 | 1.09 | 0.18 | Upgrade
|
Net Income to Common | 0.12 | -1.77 | -1.05 | 0.25 | 1.09 | 0.18 | Upgrade
|
Net Income Growth | - | - | - | -76.90% | 519.89% | - | Upgrade
|
Shares Outstanding (Basic) | 599 | 598 | 597 | 597 | 543 | 345 | Upgrade
|
Shares Outstanding (Diluted) | 607 | 598 | 597 | 601 | 547 | 347 | Upgrade
|
Shares Change (YoY) | 1.59% | 0.17% | -0.56% | 9.81% | 57.55% | 35.51% | Upgrade
|
EPS (Basic) | 0.00 | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
EPS (Diluted) | 0.00 | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
EPS Growth | - | - | - | -78.89% | 300.60% | - | Upgrade
|
Free Cash Flow | -7.66 | 3.19 | 10.86 | 3.19 | 2.86 | 0.21 | Upgrade
|
Free Cash Flow Per Share | -0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.00 | Upgrade
|
Gross Margin | 45.93% | 48.98% | 32.72% | 39.74% | 28.44% | 15.69% | Upgrade
|
Operating Margin | 2.43% | 3.02% | -10.85% | 2.36% | 10.28% | 4.84% | Upgrade
|
Profit Margin | 1.37% | -21.86% | -17.15% | 4.68% | 9.19% | 1.65% | Upgrade
|
Free Cash Flow Margin | -88.70% | 39.40% | 177.23% | 59.15% | 24.10% | 2.00% | Upgrade
|
EBITDA | 0.5 | 0.53 | -0.22 | 0.68 | 1.67 | 0.77 | Upgrade
|
EBITDA Margin | 5.75% | 6.55% | -3.57% | 12.61% | 14.04% | 7.21% | Upgrade
|
D&A For EBITDA | 0.29 | 0.29 | 0.45 | 0.55 | 0.45 | 0.25 | Upgrade
|
EBIT | 0.21 | 0.24 | -0.67 | 0.13 | 1.22 | 0.52 | Upgrade
|
EBIT Margin | 2.43% | 3.02% | -10.85% | 2.36% | 10.28% | 4.84% | Upgrade
|
Effective Tax Rate | 91.95% | 52.74% | - | 207.38% | 19.91% | 61.57% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.